ulotaront investigational TAAR1
Selected indexed studies
- Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter function. (Mol Pharmacol, 2025) [PMID:40840012]
- TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes. (Diabetes Obes Metab, 2024) [PMID:38533552]
- A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II. (Diabetes Obes Metab, 2026) [PMID:41126397]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter function. (2025) pubmed
- TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes. (2024) pubmed
- A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II. (2026) pubmed
- Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities. (2025) pubmed
- An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I. (2026) pubmed
- Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions. (2021) pubmed